Review article · 2023

Advancement of Targeted Protein Degradation Strategies As Therapeutics for Undruggable Disease Targets

Kannan Mayuri, Sarojini Sreeraman, Chaitanya Sree Somala, Raja Babu Singh Kushwah, Konda Mani Saravanan, Vickram Sundaram, Thirunavukarasou Anand

Future Medicinal Chemistry, 15(10), 867–883 · Published 1 May 2023 · DOI 10.4155/fmc-2023-0072

View at the publisherCite this paper

In brief

“Advancement of Targeted Protein Degradation Strategies As Therapeutics for Undruggable Disease Targets” is a 2023 review article by Kannan Mayuri and 6 co-authors, published in Future Medicinal Chemistry. OpenAlex counts 65 citations as of 21 November 2026, which puts it in the top 6% of works published in 2023 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
65
Most cited in
2025 (45)
Field-weighted impact
1.44
References
97
Authors
7

Abstract

Targeted protein degradation (TPD) aids in developing novel bifunctional small-molecule degraders and eliminates proteins of interest. The TPD approach shows promising results in oncological, neurogenerative, cardiovascular and gynecological drug development. We provide an overview of technology advancements in TPD, including molecular glues, proteolysis-targeting chimeras (PROTACs), lysosome-targeting chimeras, antibody-based PROTAC, GlueBody PROTAC, autophagy-targeting chimera, autophagosome-tethering compound… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Mayuri, K., Sreeraman, S., Somala, C. S., Kushwah, R. B. S., Saravanan, K. M., Sundaram, V., & Anand, T. (2023). Advancement of Targeted Protein Degradation Strategies As Therapeutics for Undruggable Disease Targets. Future Medicinal Chemistry, 15(10), 867–883. https://doi.org/10.4155/fmc-2023-0072

MLA 9

Mayuri, Kannan, et al. “Advancement of Targeted Protein Degradation Strategies As Therapeutics for Undruggable Disease Targets.” Future Medicinal Chemistry, vol. 15, no. 10, 2023, pp. 867–883. https://doi.org/10.4155/fmc-2023-0072.

Chicago

Mayuri, Kannan, Sarojini Sreeraman, Chaitanya Sree Somala, Raja Babu Singh Kushwah, Konda Mani Saravanan, Vickram Sundaram, and Thirunavukarasou Anand. 2023. “Advancement of Targeted Protein Degradation Strategies As Therapeutics for Undruggable Disease Targets.” Future Medicinal Chemistry 15 (10): 867–883. https://doi.org/10.4155/fmc-2023-0072.

Harvard

Mayuri, K. et al. (2023) ‘Advancement of Targeted Protein Degradation Strategies As Therapeutics for Undruggable Disease Targets’, Future Medicinal Chemistry, 15(10), pp. 867–883. doi:10.4155/fmc-2023-0072.

IEEE

K. Mayuri et al., “Advancement of Targeted Protein Degradation Strategies As Therapeutics for Undruggable Disease Targets,” Future Medicinal Chemistry, vol. 15, no. 10, pp. 867–883, 2023, doi: 10.4155/fmc-2023-0072.

BibTeX

@article{mayuri2023advancement,
  title     = {{Advancement of Targeted Protein Degradation Strategies As Therapeutics for Undruggable Disease Targets}},
  author    = {Mayuri, Kannan and Sreeraman, Sarojini and Somala, Chaitanya Sree and Kushwah, Raja Babu Singh and Saravanan, Konda Mani and Sundaram, Vickram and Anand, Thirunavukarasou},
  journal   = {Future Medicinal Chemistry},
  year      = {2023},
  volume    = {15},
  number    = {10},
  pages     = {867--883},
  doi       = {10.4155/fmc-2023-0072},
  url       = {https://doi.org/10.4155/fmc-2023-0072}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202333
202455
20254545
20261212

Its field-weighted citation impact is 1.44: it has been cited 1.44 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors

  • targeted protein degradation
  • PROTACs
  • molecular glues
  • lysosome-targeting chimeras
  • chaperone-mediated autophagy
  • endolysosomal pathway
  • drug development

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Mayuri, K., Sreeraman, S., Somala, C. S., Kushwah, R. B. S., Saravanan, K. M., Sundaram, V., & Anand, T. (2023). Advancement of Targeted Protein Degradation Strategies As Therapeutics for Undruggable Disease Targets. Future Medicinal Chemistry, 15(10), 867–883. https://doi.org/10.4155/fmc-2023-0072

How many times has this paper been cited?

65 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Kannan Mayuri, Sarojini Sreeraman, Chaitanya Sree Somala, Raja Babu Singh Kushwah, Konda Mani Saravanan, Vickram Sundaram, Thirunavukarasou Anand.

What is the DOI of this paper?

10.4155/fmc-2023-0072, permanently at https://doi.org/10.4155/fmc-2023-0072. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.